Zhuhai Sailong Pharmaceutical Co Ltd (002898) — Capital Reinvestment Ratio

Latest as of June 2025: 0.87x

Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a Capital Reinvestment Ratio of 0.87x as of June 2025, meaning it reinvests 1% of its operating cash flow (CN¥4.75 Million) in capital expenditures (CN¥4.15 Million). See Zhuhai Sailong Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.87x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥4.75 Million
CNY

Capital Expenditures

CN¥4.15 Million
CNY

Data as of

Jun 2025
Most recent filing

Zhuhai Sailong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)

This chart tracks Zhuhai Sailong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 11 annual periods.

Annual Capital Reinvestment Ratio for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)

Year-by-year Capital Reinvestment Ratio for Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see how much is Zhuhai Sailong Pharmaceutical Co Ltd worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 1.23x CN¥19.06 Million CN¥23.35 Million ▲ +43.1%
2023 0.86x CN¥35.71 Million CN¥30.58 Million ▼ -49.5%
2022 1.70x CN¥14.12 Million CN¥23.94 Million ▲ +91.0%
2021 0.89x CN¥35.46 Million CN¥31.47 Million ▼ -99.8%
2020 366.69x CN¥174.69K CN¥64.06 Million ▲ +805.2%
2018 40.51x CN¥3.33 Million CN¥134.84 Million ▲ +3554.0%
2017 1.11x CN¥85.13 Million CN¥94.38 Million ▲ +69.5%
2016 0.65x CN¥78.65 Million CN¥51.43 Million ▼ -34.3%
2015 1.00x CN¥47.44 Million CN¥47.24 Million ▲ +43.1%
2014 0.70x CN¥51.36 Million CN¥35.74 Million ▲ +712.9%
2013 0.09x CN¥64.84 Million CN¥5.55 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow